Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised D. Carnegie & Co in connection with a bond issue of MSEK 1,000
Mandate

Vinge has advised D. Carnegie & Co in connection with a bond issue of MSEK 1,000

April 19, 2016

Vinge has advised D. Carnegie & Co AB (publ) (”D. Carnegie”), listed on Nasdaq Stockholm, in connection with the company’s issue of senior unsecured bonds in the amount of MSEK 1,000 with a tenor of three years. D. Carnegie will apply for the bonds to be listed on Nasdaq Stockholm.

The proceeds from the issue, together with the proceeds from a share issue which was carried out on 5 April 2016, will be used for repayment of convertible subordinated loans (including payment of a market-based compensation for the option value related to the convertible subordinated loans) and a vendor note to Svensk Bolig Holding AB.

Vinge’s team consisted of Jesper Schönbeck, Mikael Ståhl, Sofie Bjärtun, Helena Håkansson and Josefine Larsson.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025